NCT07888075

OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC

RecruitingPHASE2, PHASE3INTERVENTIONAL

Trial Details

Start: 2027-02Est. Completion: 2028-10

Enrollment target: 400 participants

Contact

Clinical Trial Officeclinical@aveooncology.com +1-854-400-0101

Other microbiome trials you might be interested in

A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer CachexiaPhase 2Recruiting

Cachexia-Anorexia SyndromeCachexia; Cancer

This is a multicenter, randomized, double-blind, placebo-controlled, dose-finding Phase II clinical study to evaluate th…

Beijing, ChinaEst. completion Aug 2027

View Trial →

Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticPhase 3Recruiting

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast AdenocarcinomaHER2/Neu NegativeLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.